195 related articles for article (PubMed ID: 11106135)
1. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie YJ; Nandy S; Pecknold JC; Hadrava V; Lane RM
J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
[TBL] [Abstract][Full Text] [Related]
2. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
Liebowitz MR; DeMartinis NA; Weihs K; Londborg PD; Smith WT; Chung H; Fayyad R; Clary CM
J Clin Psychiatry; 2003 Jul; 64(7):785-92. PubMed ID: 12934979
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
5. Sertraline for social phobia: a double-blind, placebo-controlled crossover study.
Katzelnick DJ; Kobak KA; Greist JH; Jefferson JW; Mantle JM; Serlin RC
Am J Psychiatry; 1995 Sep; 152(9):1368-71. PubMed ID: 7653696
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
Stein MB; Liebowitz MR; Lydiard RB; Pitts CD; Bushnell W; Gergel I
JAMA; 1998 Aug; 280(8):708-13. PubMed ID: 9728642
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response in generalized social phobia: effect of age of onset.
Van Ameringen M; Oakman J; Mancini C; Pipe B; Chung H
J Clin Psychopharmacol; 2004 Feb; 24(1):42-8. PubMed ID: 14709946
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional effects of sertraline in social anxiety disorder.
Connor KM; Davidson JR; Chung H; Yang R; Clary CM
Depress Anxiety; 2006; 23(1):6-10. PubMed ID: 16216019
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
Rickels K; Mangano R; Khan A
J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
Liebowitz MR; Mangano RM; Bradwejn J; Asnis G;
J Clin Psychiatry; 2005 Feb; 66(2):238-47. PubMed ID: 15705011
[TBL] [Abstract][Full Text] [Related]
16. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
[TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
Londborg PD; Hegel MT; Goldstein S; Goldstein D; Himmelhoch JM; Maddock R; Patterson WM; Rausch J; Farfel GM
J Clin Psychiatry; 2001 May; 62(5):325-31. PubMed ID: 11411812
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
[TBL] [Abstract][Full Text] [Related]
19. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.
Fahlén T; Nilsson HL; Borg K; Humble M; Pauli U
Acta Psychiatr Scand; 1995 Nov; 92(5):351-8. PubMed ID: 8619339
[TBL] [Abstract][Full Text] [Related]
20. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
